Drug Trial Radar · NCT01718236
Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section
Last checked: Nov 20, 2026Latest source record: Jul 26, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Sep 2012
Primary completion
Jan 2015
Study completion Jan 2015
Sponsor
- Lead sponsor
- Brno University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- St. Anne's University Hospital Brno, Czech Republic; University Hospital Olomouc; IGA - internal grant agency, Ministry of Health
- First posted
- Oct 31, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- Female only, from 14 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The project aims to introduce into clinical practice for Caesarean section conducted under general anesthesia with the rapid induction myorelaxation with rocuronium and the reversal of neuromuscular blockade by using sugammadex. The aim is to demonstrate at least the same efficiency and confirm the safety of the procedure for both mother and newborn compared with older procedure.
Conditions
- Caesarean Section
- Pregnancy
Interventions
Rocuronium + sugammadexDrug
Administration of rocuronium 1 mg/kg, intubation at decrease in Single Twitch to 10% of baseline event. by the disappearance of visible spikes event. in the 60th seconds after administration of muscle relaxants. Anesthesia with sevoflurane according to the MAC, neuromuscular blockade TOF count at 1-2.At the end of operation at PTC 1-2 sugammadex 4 mg/kg, at the TOF count 1-2, sugammadex 2 mg/kg, in the case of failure to achieve these values the anesthesiologist will wait until the minimum value of PTC 1-2 will be achieved. In can not intubate can not ventilate, and the failure of the introduction of laryngeal masks sugammadex 16mg/kg, immediately following the discovery of this fact and wait for the recovery of muscle strength. Time to recovery is recorded.
Succinylcholine + NeostigmineDrug
1mg/kg succinylcholine iodide, intubation after decrease in Single Twitch to 10% of baseline event. after the disappearance of visible fasciculation event. in the 60th seconds after administration of muscle relaxants. Anesthesia with sevoflurane according to the MAC, at the moment of 20-30% of the original value of Single Twitch rocuronium 0.3 mg / kg, maintaining TOF Count at 1-2.At the end of operation at TOF Count 1-2 atropine 0.01 mg/kg and neostigmine 0.03 mg/kg. If TOF not 1-2 wait.In can not intubate can not ventilate, wait for the spontaneous recovery. Time to recovery of muscle strength is recorded.
Primary outcomes
What the sponsor says the trial is designed to measure.
- time needed to tracheal intubationTime frame: 2 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Faculty Hospital Olomouc
Olomouc, Olomouc Region, Czechia
Faculty hospital Brno
Brno, South Moravian, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.